Investors NYSE AMERICAN: LCTX Data Provided by Refinitiv. Minimum 15 minutes delayed. VIEW STOCK QUOTE Press Releases November 16, 2020 Lineage Cell Therapeutics Presents New OpRegen® Data for Dry AMD With GA at 2020 American Academy of Ophthalmology Annual Meeting November 13, 2020 Lineage Cell Therapeutics Proudly Supports Patients’ Access to Innovative Cell Therapy Treatments and Research Through Passage of Proposition 14 November 11, 2020 Lineage Cell Therapeutics Completes Patient Enrollment in Phase 1/2a Clinical Study of OpRegen® Cell Therapy for the Treatment of Dry Age-related Macular Degeneration VIEW PRESS RELEASES Events & Presentations Therapeutic Expert Call to Discuss OpRegen Phase 1/2a Study Interim Results (2020 American Academy of Ophthalmology Update) Nov 17, 2020 at 4:00 PM EST Noble Capital Markets & Channelchek Virtual Roadshow Series: Lineage Cell Therapeutics, Inc. Nov 10, 2020 at 1:00 PM EST Third Quarter 2020 Financial Results Earnings Call Nov 4, 2020 at 4:30 PM EST VIEW EVENTS & PRESENTATIONS
November 16, 2020 Lineage Cell Therapeutics Presents New OpRegen® Data for Dry AMD With GA at 2020 American Academy of Ophthalmology Annual Meeting
November 13, 2020 Lineage Cell Therapeutics Proudly Supports Patients’ Access to Innovative Cell Therapy Treatments and Research Through Passage of Proposition 14
November 11, 2020 Lineage Cell Therapeutics Completes Patient Enrollment in Phase 1/2a Clinical Study of OpRegen® Cell Therapy for the Treatment of Dry Age-related Macular Degeneration
Therapeutic Expert Call to Discuss OpRegen Phase 1/2a Study Interim Results (2020 American Academy of Ophthalmology Update) Nov 17, 2020 at 4:00 PM EST
Noble Capital Markets & Channelchek Virtual Roadshow Series: Lineage Cell Therapeutics, Inc. Nov 10, 2020 at 1:00 PM EST
